Analysts predict that U.S. Physical Therapy, Inc. (NYSE:USPH) will post earnings per share (EPS) of $0.68 for the current quarter, Zacks Investment Research reports. Three analysts have provided estimates for U.S. Physical Therapy’s earnings, with estimates ranging from $0.68 to $0.69. U.S. Physical Therapy reported earnings of $0.71 per share during the same quarter last year, which indicates a negative year-over-year growth rate of 4.2%. The business is expected to report its next quarterly earnings report on Thursday, March 5th.
On average, analysts expect that U.S. Physical Therapy will report full year earnings of $2.86 per share for the current fiscal year, with EPS estimates ranging from $2.86 to $2.87. For the next fiscal year, analysts anticipate that the business will report earnings of $3.15 per share, with EPS estimates ranging from $3.05 to $3.25. Zacks Investment Research’s earnings per share averages are an average based on a survey of sell-side research analysts that that provide coverage for U.S. Physical Therapy.
U.S. Physical Therapy (NYSE:USPH) last announced its earnings results on Thursday, November 7th. The company reported $0.71 EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.71. U.S. Physical Therapy had a return on equity of 16.57% and a net margin of 6.36%. The firm had revenue of $117.30 million for the quarter, compared to analysts’ expectations of $121.28 million. During the same quarter in the previous year, the company earned $0.64 earnings per share. The firm’s quarterly revenue was up 3.7% compared to the same quarter last year.
USPH has been the topic of a number of research reports. Barrington Research upgraded shares of U.S. Physical Therapy from a “market perform” rating to an “outperform” rating and set a $130.00 target price on the stock in a research report on Friday, November 8th. ValuEngine upgraded shares of U.S. Physical Therapy from a “hold” rating to a “buy” rating in a report on Friday, November 1st. Finally, Zacks Investment Research downgraded shares of U.S. Physical Therapy from a “hold” rating to a “sell” rating in a report on Thursday, December 5th. One equities research analyst has rated the stock with a sell rating and three have given a buy rating to the company’s stock. The company has an average rating of “Buy” and an average price target of $127.20.
Shares of NYSE USPH traded up $0.04 during midday trading on Wednesday, reaching $116.95. The stock had a trading volume of 3,684 shares, compared to its average volume of 90,437. The firm has a market cap of $1.49 billion, a price-to-earnings ratio of 44.21, a price-to-earnings-growth ratio of 3.33 and a beta of 1.05. U.S. Physical Therapy has a twelve month low of $98.69 and a twelve month high of $148.48. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.47 and a current ratio of 1.47. The company’s 50 day moving average price is $125.04 and its 200 day moving average price is $126.50.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 13th. Shareholders of record on Monday, November 18th will be issued a dividend of $0.30 per share. The ex-dividend date of this dividend is Friday, November 15th. This represents a $1.20 annualized dividend and a yield of 1.03%. U.S. Physical Therapy’s payout ratio is 45.28%.
In other news, Director Mark J. Brookner sold 1,000 shares of the company’s stock in a transaction on Thursday, November 21st. The shares were sold at an average price of $116.25, for a total value of $116,250.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Lawrance W. Mcafee sold 402 shares of the company’s stock in a transaction on Friday, November 22nd. The stock was sold at an average price of $116.42, for a total transaction of $46,800.84. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 4,476 shares of company stock worth $515,700. Corporate insiders own 2.50% of the company’s stock.
Several hedge funds and other institutional investors have recently bought and sold shares of USPH. Arizona State Retirement System grew its stake in shares of U.S. Physical Therapy by 1.2% in the 2nd quarter. Arizona State Retirement System now owns 19,795 shares of the company’s stock worth $2,426,000 after acquiring an additional 227 shares in the last quarter. Los Angeles Capital Management & Equity Research Inc. purchased a new stake in U.S. Physical Therapy during the second quarter valued at about $2,421,000. Aperio Group LLC lifted its holdings in U.S. Physical Therapy by 17.1% during the second quarter. Aperio Group LLC now owns 6,174 shares of the company’s stock valued at $757,000 after purchasing an additional 903 shares during the last quarter. Advisor Group Inc. lifted its holdings in U.S. Physical Therapy by 6.5% during the second quarter. Advisor Group Inc. now owns 2,319 shares of the company’s stock valued at $285,000 after purchasing an additional 141 shares during the last quarter. Finally, Envestnet Asset Management Inc. lifted its holdings in U.S. Physical Therapy by 12.9% during the second quarter. Envestnet Asset Management Inc. now owns 28,002 shares of the company’s stock valued at $3,432,000 after purchasing an additional 3,206 shares during the last quarter.
U.S. Physical Therapy Company Profile
U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for U.S. Physical Therapy Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for U.S. Physical Therapy and related companies with MarketBeat.com’s FREE daily email newsletter.